UZ-UCSF CTU: Advancing HIV treatment and prevention through shared clinical trials
Official title: UZ-UCSF CTU
Funded at University of California, San Francisco · NIH-11597193 · Data updated 2026-11-12
A collaborative HIV-focused clinical trials unit in Zimbabwe and at UCSF works on multiple phases of HIV care and prevention to improve health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 16, 2026 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $629,318 |
| NIH project number | 3UM1AI069436-20S3 |
| Project ID | NIH-11597193 on NIH RePORTER |
Who could benefit from this research
✓Could help
Potential participants include people living with HIV or at risk for HIV, including adults and adolescents, enrolled in ongoing or upcoming ACTG, IMPAACT, HPTN, or HVTN trials.
✕Less likely to help
Some individuals may not directly benefit if they are not eligible for specific trials or if study results do not apply to their situation.
What this research studies
This grant supports the University of California, San Francisco Clinical Trials Unit in Zimbabwe to lead and participate in high-quality HIV studies across major networks. It emphasizes training local researchers, coordinating trials at several sites, and contributing to global HIV and TB knowledge and policy. The work aims to develop durable ARV-based treatment and preventive strategies, while strengthening the research infrastructure and standards of care in Zimbabwe and beyond. Participants could be adults or adolescents living with or at risk for HIV, contributing data and samples as part of multi-network trials.
Why it matters
Potential benefit: If successful, patients could experience faster access to new HIV treatments and prevention options, plus improved care standards.
How similar studies have gone: Past CTU efforts have enrolled thousands of participants and produced numerous publications guiding HIV care and policy.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Chirenje, Zvavahera Mike — University of California, San Francisco
- Study coordinator: Chirenje, Zvavahera Mike
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.